|
|
Volumn 55, Issue 10, 1998, Pages 1551-1556
|
|
Selective depletion of DNA precursors: An evolving strategy for potentiation of dideoxynucleoside activity against human immunodeficiency virus
|
|
Author keywords
Anti HIV drugs; Combination therapy; Dideoxynucleosides; Drug resistance; HIV 1 mutants; HIV 1 replication
|
|
Indexed keywords
2',3' DIDEOXYNUCLEOSIDE DERIVATIVE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
DEOXYNUCLEOSIDE TRIPHOSPHATE;
DIDANOSINE;
HYDROXYUREA;
UNCLASSIFIED DRUG;
ANTIMICROBIAL THERAPY;
COST EFFECTIVENESS ANALYSIS;
DNA REPLICATION;
DNA SYNTHESIS INHIBITION;
DRUG ACTIVITY;
DRUG POTENTIATION;
DRUG RESISTANCE;
GENE MUTATION;
HUMAN IMMUNODEFICIENCY VIRUS 1;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN DEPLETION;
REVERSE TRANSCRIPTION;
REVIEW;
VIRUS GENOME;
VIRUS INHIBITION;
VIRUS REPLICATION;
|
|
EID: 0032524983
PISSN: 00062952
EISSN: None
Source Type: Journal
DOI: 10.1016/S0006-2952(97)00664-3 Document Type: Note |
|
Times cited : (37)
|
|
References (56)
|
